Tiesha Brown

Tiesha Brown supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurement activities that enable public health infrastructure and scientific response capabilities. She manages the acquisition of specialized health services and diagnostic solutions critical to infectious disease surveillance, laboratory capacity building, and epidemiological data operations. Her work ensures timely access to high-integrity clinical and laboratory services that underpin CDC’s national health security priorities, with a focus on rapid deployment of testing, diagnostics, and ambulatory health support systems. Brown maintains consistent procurement relationships with leading providers in biomedical and public health services, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, Cepheid, and the New York City Health & Hospitals Corporation. These partnerships reflect a reliance on established industry leaders with proven expertise in diagnostic technologies, laboratory systems, and large-scale public health service delivery. Her contracting approach emphasizes performance-based outcomes, compliance with federal health standards, and the integration of scalable, evidence-based solutions into CDC’s operational framework. Brown’s procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on selecting the most technically capable and operationally ready vendors to meet urgent public health demands, prioritizing capability and readiness over socioeconomic classifications. While small business participation is not formally targeted, all acquisitions adhere strictly to federal acquisition regulations and competitive bidding protocols. Her primary focus lies within NAICS 621999—All Other Miscellaneous Ambulatory Health Care Services—encompassing specialized diagnostic testing, mobile health response units, and outsourced clinical support services essential to outbreak response and surveillance. She specializes in procuring complex, high-throughput laboratory systems, point-of-care diagnostics, and data-enabled health service platforms that support CDC’s real-time public health decision-making infrastructure.